Results 141 to 150 of about 797,268 (256)

Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction

, 2014
Yoshiaki Kitaguchi,1,2 Keisaku Fujimoto,3 Masayuki Hanaoka,1 Takayuki Honda,4 Junichi Hotta,2 Jiro Hirayama2 1First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, 2Department of Internal Medicine, Okaya City Hospital ...
Kitaguchi Y, Hanaoka M, Hirayama J, Hotta J, Fujimoto K, Honda T   +5 more
core  

Hepatoid Carcinoma of the Lung: A Rare Presentation

Respirology Case Reports, Volume 14, Issue 11, November 2026.
We describe an alpha‐fetoprotein‐negative hepatoid adenocarcinoma of the lung diagnosed after resection of a small solitary pulmonary nodule and discuss the diagnostic and therapeutic implications. ABSTRACT Hepatoid adenocarcinoma of the lung (HAL) is a rare pulmonary malignancy that resembles hepatocellular carcinoma morphologically and poses ...
Cláudia Martinho, Miguel Afonso, Vânia Almeida, João Couto, Alexandra Cunha   +4 more
wiley   +1 more source

Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema. [PDF]

Int J Mol Sci, 2023
Desplanche E, Grillet PE, Wynands Q, Bideaux P, Alburquerque L, Charrabi A, Bourdin A, Cazorla O, Gouzi F, Virsolvy A.   +9 more
europepmc   +1 more source

A Rare Endobronchial Lipoma of the Right Middle Lobe Causing Middle Lobe Syndrome and Recurrent Post‐Obstructive Infection in a Patient With Interstitial Lung Disease, Managed by Lung‐Sparing Bronchoscopy

Respirology Case Reports, Volume 14, Issue 11, November 2026.
A 70‐year‐old smoker with combined pulmonary fibrosis and emphysema presented with recurrent right middle lobe infections and declining pulmonary function. This case describes bronchoscopic diagnosis of endobronchial lipoma and treatment of benign obstruction in persistent middle lobe disease, highlighting the need for longer surveillance to assess ...
Anastasios Palamidas, Kostandinos Papatheodosiou, Evagelia Karagianni, Fotios Daglis, Demosthenes Bouros   +4 more
wiley   +1 more source

Impaired Alveolar Re-Epithelialization in Pulmonary Emphysema. [PDF]

Cells, 2022
Lin CR, Bahmed K, Kosmider B.
europepmc   +1 more source

Valve Expectoration After Endobronchial Valve Placement: Potential Utility of Computed Tomography‐Based Airway Sizing—A Case Report

Respirology Case Reports, Volume 14, Issue 11, November 2026.
After a 75‐year‐old man with COPD expectorated an endobronchial valve, retrospective analysis of preprocedural dynamic CT showed left B10 diameter increasing from 4.25 mm at end‐expiration to 6.55 mm at end‐inspiration, near the size 4.0 valve's upper working limit. Inspiratory CT may aid valve placement planning and size selection.
Daisuke Kinose, Yukihiro Nagatani, Hiroaki Nakagawa, Mayu Fujino, Amane Ichida, Reo Tanaka, Shogo Okuda, Yasumitsu Ueki, Masashi Misonou, Akio Yamazaki, Emiko Ogawa, Masafumi Yamaguchi, Yasutaka Nakano   +12 more
wiley   +1 more source

Dark-Field Chest Radiography Outperforms Conventional Chest Radiography for the Diagnosis and Staging of Pulmonary Emphysema. [PDF]

Invest Radiol, 2023
Urban T, Sauter AP, Frank M, Willer K, Noichl W, Bast H, Schick R, Herzen J, Koehler T, Gassert FT, Bodden JH, Fingerle AA, Gleich B, Renger B, Makowski MR, Pfeiffer F, Pfeiffer D.   +16 more
europepmc   +1 more source

Coinfections With Respiratory Syncytial Virus in a Cohort of Adults With High‐Risk Conditions, 2015–2020: A Retrospective Observational Study

Health Science Reports, Volume 9, Issue 11, November 2026.
Oluwakemi D. Alonge, Maria E. Sundaram, Huong Q. Nguyen, Jennifer P. King, Elisha Stefanski, Andrew G. Allmon, Jean‐Yves Pirçon, Pouya Saeedi   +7 more
wiley   +1 more source

Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema

Respirology, Volume 31, Issue 11, Page 1117-1125, November 2026.
This multicentre prospective study of 1016 patients demonstrated that CPFE, defined as ≥ 5% emphysema on visual CT assessment, identified a high‐risk phenotype with significantly worse 5‐year survival compared to non‐CPFE IIP patients (51.4% vs. 63.1%) and COPD patients (51.4% vs. 84.0%) and higher acute exacerbation incidence, validating international
Kazuya Tsubouchi, Yasuaki Kotetsu, Tomotsugu Takano, Hiroaki Ogata, Fumiaki Kiyomi, Katsuyuki Ichiki, Shohei Takata, Yasuhiko Kitasato, Hiroshi Ishii, Kazuhiro Yatera, Kei Yamasaki, Masaki Okamoto, Makoto Yoshida, Masayuki Kawasaki, Masaki Fujita, Tomohiro Ogawa, Kazunori Tobino, Eiji Harada, Noriaki Nakagaki, Masashi Komori, Taishi Harada, Hiroshi Wataya, Yoichi Nakanishi, Isamu Okamoto   +23 more
wiley   +1 more source

B1 cells drive pulmonary emphysema progression through ADAM10. [PDF]

Respir Res
Lv R, Li Z, Zhao C, Wang M, Shi F, Lu C, Duan J, Xu X.   +7 more
europepmc   +1 more source